Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Boston Scientific | 46 | 0 | 13 | 0 | €66.50 | €72.96 | 9.709% |
| Stryker Corp. | 22 | 0 | 10 | 0 | €304.50 | €335.03 | 10.026% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €459.85 | €543.72 | 18.239% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 7 | 1 | €874.40 | €957.22 | 9.472% |
| Eli Lilly Corp. | 51 | 0 | 7 | 0 | €704.90 | €766.92 | 8.798% |
| Humana Inc. | 23 | 0 | 6 | 0 | €299.30 | €439.88 | 46.968% |
| HCA Holdings Inc. | 22 | 0 | 6 | 0 | €291.70 | €295.60 | 1.336% |
| Thermo Fisher Scientific Inc. | 27 | 0 | 6 | 0 | €532.60 | €568.09 | 6.664% |
| Centene Corp. | 15 | 0 | 5 | 0 | €69.30 | €82.57 | 19.149% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €60.91 | €86.77 | 42.458% |
| Biogen Inc. | 44 | 2 | 4 | 1 | €198.80 | €293.57 | 47.672% |
| Abbott Laboratories | 16 | 0 | 4 | 0 | €98.76 | €116.81 | 18.274% |
| Zoetis Inc. A | 21 | 1 | 4 | 1 | €155.90 | €200.06 | 28.324% |
| Intuitive Surgical Inc | 34 | 0 | 4 | 0 | €352.15 | €370.00 | 5.069% |
| Align Technology | 15 | 2 | 4 | 0 | €267.20 | €345.95 | 29.472% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | €372.90 | €382.71 | 2.629% |
| Dexcom Inc. | 18 | 0 | 3 | 0 | €118.04 | €136.82 | 15.912% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €77.98 | €102.62 | 31.597% |
| Resmed Inc. | 19 | 0 | 3 | 0 | €203.40 | €207.72 | 2.122% |
| Amgen Inc. | 21 | 0 | 3 | 0 | €259.65 | €294.28 | 13.338% |
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | €79.31 | €87.48 | 10.295% |
| AbbVie Inc. | 20 | 1 | 3 | 1 | €149.92 | €174.43 | 16.351% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €119.60 | €124.93 | 4.456% |
| Pfizer Inc. | 30 | 4 | 2 | 1 | €25.83 | €41.10 | 59.129% |
| Hologic Inc. | 13 | 0 | 2 | 0 | €71.00 | €84.03 | 18.355% |